149 related articles for article (PubMed ID: 38073330)
1. Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription.
Jiang B; Yan B; Yang H; Geng H; Li P
J Microbiol Biotechnol; 2024 Apr; 34(4):920-929. PubMed ID: 38073330
[TBL] [Abstract][Full Text] [Related]
2. LINC00174 Facilitates Proliferation and Migration of Colorectal Cancer Cells via MiR-3127-5p/ E2F7 Axis.
Ma Y; Li Y; Tang Y; Tang N; Wang D; Li X
J Microbiol Biotechnol; 2021 Aug; 31(8):1098-1108. PubMed ID: 34226413
[TBL] [Abstract][Full Text] [Related]
3. CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer.
Wang L; Wang Y; Wang C; Yang K; Ye G
J Mol Histol; 2023 Oct; 54(5):489-498. PubMed ID: 37615745
[TBL] [Abstract][Full Text] [Related]
4. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis.
Yuan Y; Zhou X; Kang Y; Kuang H; Peng Q; Zhang B; Liu X; Zhang M
Life Sci; 2021 Feb; 267():118955. PubMed ID: 33359669
[TBL] [Abstract][Full Text] [Related]
5. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion.
Bae S; Oh K; Kim H; Kim Y; Kim HR; Hwang YI; Lee DS; Kang JS; Lee WJ
Immunobiology; 2013 Aug; 218(8):1026-33. PubMed ID: 23434435
[TBL] [Abstract][Full Text] [Related]
6. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression.
Liu W; Song Y; Zhang C; Gao P; Huang B; Yang J
Biomed Pharmacother; 2018 Aug; 104():94-101. PubMed ID: 29772445
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
[TBL] [Abstract][Full Text] [Related]
8. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.
Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J
Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
10. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
Zhao Y; Zhu C; Chang Q; Peng P; Yang J; Liu C; Liu Y; Chen X; Liu Y; Cheng R; Wu Y; Wu X; Hu L; Yin J
PLoS One; 2020; 15(11):e0242179. PubMed ID: 33201900
[TBL] [Abstract][Full Text] [Related]
11. miR-24 inhibited the killing effect of natural killer cells to colorectal cancer cells by downregulating Paxillin.
Zhang LL; Zhang LF; Shi YB
Biomed Pharmacother; 2018 May; 101():257-263. PubMed ID: 29494963
[TBL] [Abstract][Full Text] [Related]
12. RAD18 promotes colorectal cancer metastasis by activating the epithelial‑mesenchymal transition pathway.
Li P; He C; Gao A; Yan X; Xia X; Zhou J; Wu J
Oncol Rep; 2020 Jul; 44(1):213-223. PubMed ID: 32319669
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
[TBL] [Abstract][Full Text] [Related]
14. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1.
Zhu SY; Wu QY; Zhang CX; Wang Q; Ling J; Huang XT; Sun X; Yuan M; Wu D; Yin HF
Biochem Biophys Res Commun; 2018 Oct; 505(1):309-316. PubMed ID: 30249397
[TBL] [Abstract][Full Text] [Related]
15. MiR-137 targets and regulates E2F7 to suppress progression of glioma cells.
Li J; Gu J; Wang J; You A; Zhang Y; Rao G; Li S; Ge X; Zhang K; Wu X; Cheng L; Zhu M; Wang D
Folia Neuropathol; 2022; 60(3):346-354. PubMed ID: 36382488
[TBL] [Abstract][Full Text] [Related]
16. E2F7/RAD51AP1 Axis Inhibits Endometrial Cancer Sensitivity to 5-FU
Huang X; Wu Z; Xiao C; Chen XI
Anticancer Res; 2023 Nov; 43(11):4905-4914. PubMed ID: 37909953
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-301a-3p inhibited the killing effect of natural killer cells on non-small cell lung cancer cells by regulating RUNX3.
Zhang J; Yang Y; Wei Y; Li L; Wang X; Ye Z
Cancer Biomark; 2023; 37(4):249-259. PubMed ID: 37302028
[TBL] [Abstract][Full Text] [Related]
18. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis.
Lu T; Wei GH; Wang J; Shen J
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10462-10471. PubMed ID: 33155202
[TBL] [Abstract][Full Text] [Related]
20. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
